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Background: Conscious sedation in dental treatment of patients with special needs (PNEs) has the purpose of 
controlling events such as anxiety and fear, as well as promoting muscle relaxation and mastery of uncoordinated 
movements. Benzodiazepines (BZDs) are among the most used drugs due to their anxiolytic, hypnotic and sedative 
properties. The objective of this investigation is to demonstrate a study on the contribution of conscious sedation 
with BZD in PNEs. 
Material and Methods: The study included 40 PNEs, non-collaborators, submitted to conscious oral sedation with 
Midazolam (0.5 mg/kg) for dental treatment, receiving vital signs monitoring in the pre, trans and postoperative 
periods. 
Results: Male patients were more frequent with 70% of the cases, with a mean age of 18 years. As for medical 
diagnosis, autism and mental deficiency were the most prevalent. The most performed procedures were restoration 
(32%) and exodontia (30%). There was a statistically significant reduction in systolic and diastolic blood pressure 
parameters (p<0.05) in the transoperative and postoperative periods when compared to the preoperative period. 
Conscious sedation with BZDs resulted in 83% positive responses. 
Conclusions: The results demonstrate that this technique is safe and effective, and can be used in outpatient care for 
PNEs. However, the risk/benefit ratio should be correctly evaluated.
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Introduction
Dental care for patients with special needs (PNEs) co-
vers a diverse group of people with one or more health 
conditions, whether chronic or acute, requiring specia-
lized and individualized clinical management (1). One 
of the great challenges for adequate outpatient care is 
to make the patient to collaborate, which in many cases 
does not happen due to fear and anxiety. In addition, the 
patient may not be able to develop emotional control of 
these factors or may not have full intellectual develop-
ment, and their capacity for understanding and coopera-
tion may be affected (1).
The first option is to apply methods of psychological 
conditioning, however, they may not be sufficient for 
adequate dental treatment. In these cases, conscious 
sedation is an effective and safe alternative that allows 
the patient to become more cooperative, promoting the 
accomplishment of a less traumatic and more resilient 
treatment. The main objectives of sedation are reduction 
of anxiety and fear, as well as mild analgesia and reduc-
tion of nausea and salivary flow (2-4).
Among the pharmacological methods of sedation in 
dentistry, oral benzodiazepines (BZDs) are one of the 
most widely used alternatives to this degree of sedation 
(5). They consist of a group of drugs that have proven 
efficacy and promote safety in clinical use (6). Its action 
occurs through the interaction of the drug with speci-
fic receptors in the central nervous system, promoting 
sedation, hypnosis, anxiety control, skeletal muscle re-
laxation, anterograde amnesia, anticonvulsant activity, 
reduction of salivary flow and vomiting reflex (7,8). Mi-
nimal effects may occur in the cardiovascular and respi-
ratory systems, such as mild reduction in blood pressure 
and heart and respiratory rates (7). The BZDs most used 
in dentistry are: Diazepam, Lorazepam, Alprazolam, 
Midazolam and Triazolam, being classified according 
to the onset of action and the duration of the anxiolytic 
effect (9,10). Midazolam was the drug of choice for ou-
tpatient dental procedures because, compared to other 
drugs, it allows administration in children, adults and 
older persons, has a rapid onset of action and presents a 
short duration of pharmacological effect (11).
Although studies point to oral sedation with BZDs as an 
effective option in dentistry, there are few studies that 
have evaluated the effect of this sedation on dental care 
in patients with special needs. 
The objective of this study is to evaluate the contribution 
of conscious sedation with benzodiazepines at dental 
care for patients with special needs, demonstrating the 
indication, safety and efficacy of this technique.
Material and Methods
The sample of this study consisted of 40 participants, at-
tended at the Odontological Center for Special Patients of 
the Brazilian Dental Association – RJ (COPE-ABORJ) 
for dental treatment between 2015 and 2016. The sam-
ple included patients with uncontrollable fear or anxiety, 
neuromuscular disorders, or reduced intellectual capaci-
ty, as well as those that did not collaborate or presented 
conditions that hindered or prevented the initial dental 
care and that could impair the conduction of the treat-
ment in subsequent consultations.
Instructions for oral sedation were given to inform the 
patient and/or caregiver/family about the use of benzo-
diazepine, possible adverse and side effects of the pre-
vious and posthumous sedation. For a safe dental treat-
ment, a request for medical opinion on oral sedation was 
issued for all candidates in order to complement perti-
nent clinical information as well as medications for daily 
use and possible care needed during it.
Patients were submitted to oral sedation with compres-
sed Midazolam at doses of 7.5 or 15 mg or with titra-
tion based on application of 0.5 mg/kg, not exceeding 
20 mg per consultation. Patients who were unfit for and/
or who did not respond satisfactorily after oral sedation 
were referred for hospital-level treatment under general 
anesthesia. During clinical care, blood pressure, heart 
rate and oxygen saturation were monitored in the pre, 
trans and postoperative periods, at intervals of 15 minu-
tes between each; results were obtained through digital 
sphygmomanometer and pulse oximeter.
The demographic and clinical data collected from pa-
tients corresponded to sex, skin color, age, body mass 
and diagnosis. Due to the difficulty in accurately classi-
fying all participants, the skin color was classified only 
into white, black and brown.
This study was approved by the Research Ethics Com-
mittee of the Hospital Universitário Pedro Ernesto, Uni-
versidade do Estado do Rio de Janeiro (HUPE/UERJ) 
with the number CAAE: 24279314.1.00005259.
All statistical tests used in this study were performed 
through the statistical program SPSS (Statistical Packa-
ge for the Social Sciences, version 22.0). The statistical 
description of the studied variables covered standard 
deviations, minimum-maximum and median values 
(age, blood pressure, heart rate and O2 saturation). The 
Student’s t-test was used to evaluate the differences 
between continuous quantitative variables, i.e. in the 
preoperative, intraoperative and postoperative periods, 
two to two, for analysis of blood pressure, heart rate and 
O2 saturation alone.
Results
The male sex prevailed with 28 (70%) patients and the 
most frequent skin color was white with 28 (70%) cases. 
The age ranged from 6 to 73 years, with an average of 18 
years (SD=14 years). In relation to body mass, the mean 
was 46 kg (SD=±26 kg), and male patients presented a 
higher body mass in absolute values, 55 kg (SD=±22 
kg), table 1. Of the 40 patients with special non-emplo-











































































 Table 1: Distribution of sample according to demographic and clinical profile.
yee needs, autism prevailed (28%), followed by intellec-
tual disability (15%), and Down syndrome (12%) (Table 
1). Among the dental procedures performed, restoration 
prevailed with 32%, followed by dental extraction with 
30% (Table 1).
In relation to vital signs monitoring, these parameters 
were reduced to preoperative and trans-operative pe-
riods, with a mean decrease of 2 mmHg in systolic blood 
pressure and 1 mmHg in diastolic blood pressure; and a 
reduction of 6 bpm in heart rate on average. In no case 
Parameters Preoperative Trans-operatory Postoperative p*
Arterial systolic 
pressure
116 mmHg 114 mmHg 113 mmHg p<0.01
Arterial  diastolic
pressure
80 mmHg 79 mmHg 73 mmHg p<0.01
Heart rate 92 bpm 86 bpm 82 bpm p<0.01
Oxygen saturation 97% 98% 98% Not significant
 Table 2: Parameters measured during the pre, trans and postoperative periods.
pbm = beats per minute. * = value of p≤0.05.
did the oxygen saturation reach below 96%. There was a 
statistically significant reduction in systolic and diastolic 
blood pressure parameters, as well as heart rate, between 
the pre and postoperative periods, demonstrating the 
efficacy of BZDs in anxiety control (Table 2). There was 
a statistically significant reduction in blood pressure and 
heart rate (p<0.01, Student’s t-test), with maintenance of 
satisfactory levels of oxygen saturation. In most cases 
(83%), sedation was shown to be safe and effective, as 
reported by professionals.
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Discussion
The use of various pharmacological methods of seda-
tion in dentistry has been increasing with the passage of 
time. Numerous studies are carried out with the purpose 
of describing, analyzing and improving the techniques 
and results in the dental care of patients with diagnoses 
or clinical conditions that make it difficult for the pro-
fessional to handle, thus enabling appropriate outpatient 
treatment with benefits for patients and professionals. 
This study was developed based on this assumption 
and focused on specific objectives in order to asses the 
contribution that oral sedation would have in the dental 
management of special non-collaborating patients (12).
These studies are needed to describe the profile of pa-
tients who require sedation for psychological control of 
fear and anxiety, the behavior of non-cooperative pa-
tients, and the patients’ response to sedation in terms of 
results of clinical data, such as decreased anxiety/fear 
or increased cooperation during consultations. To the 
best of out knowledge, the literature presents no inves-
tigation with a comparative methodology similar to our 
study, even though it is necessary to study the popula-
tion with clinical focus and show the real contribution 
of oral sedation for anxiety control and behavior of the 
non- cooperative patient in dental care.
In this study, we used nasal or venous drugs to control 
anxiety in dentistry (13-15). The objective was to des-
cribe the mechanism of action of the drugs used, not the 
clinical signs such as blood pressure, oxygen saturation 
and the type of procedure performed. Another fact that 
calls our attention is the type of indication or the type of 
patient who underwent oral sedation, which for us seems 
to be overwhelmed, inspiring more assistance for pedia-
tric patients without comorbidities and adults with fear 
and anxiety.
The prevalence of males in this pilot study was higher 
(70%), as in the study by Moreira et al., with 56% of the 
sample consisting of males (16); however, other studies 
reported having prevalence of female patients with 73%, 
66% and 64%, respectively (13,17,18). According to our 
results, it can be assumed that sex is not a determining 
factor that expresses the need for pharmacological se-
dation.
The mean age in the studies of Jerath et al. and Masu-
da et al. were close, with the first one being 40, with a 
minimum age of 20 years and a maximum of 85, and 
the second study being 47 years, varying from 9 to 85 
years old (14,19). When compared to the mean of our 
study (18 years), it can be observed that the means were 
higher; however, variations of ages were close to the 
present study, which presented ages from 6 to 78 years.
On the other hand, studies showed much lower mean 
age results, being 3 years and 4 months (40 months) and 
2 years and 3 months (28 months), respectively, which 
may be justified because they are studies that have ad-
dressed the use of sedatives in pediatric patients (16,17).
When analyzing the results with respect to age, initially 
one can think of two possibilities: the first is that beha-
vior management techniques and pediatric patient iatro-
sedation have not been enough in conditioning for den-
tal treatment. The second may be related to the increase 
in the life expectancy of the general population and the 
need for more complex and invasive procedures, asso-
ciated with the accumulation of comorbidities in these 
patients.
In fact, when we compare our results with the reasoning 
described previously, we believe that some limitations 
can be pointed out and increased in a more in-depth 
study and with a larger number of patients. 
These limitations are added to future studies that, besi-
des collecting the data described by us, should also add 
relationships such as the type of medication that the pa-
tient uses associated with the type of medication used 
for sedation, as well as his or her medical diagnosis. 
These variables can answer why there were cases where 
sedation had no effect or had complications during the 
procedure, as paradoxical effect, retrograde amnesia and 
profound sleepiness, for example.
Conclusions
In conclusion, benzodiazepine sedation, when well em-
ployed, is a safe and effective technique, constituting 
an option for ambulatory care of patients with special 
non-cooperative needs. However, thorough knowledge 
of this technique, its risks and benefits, and the monito-
ring of vital signs (blood pressure, heart rate and oxygen 
saturation) of the patient are essential.
References
1. Chavez EM, Wong LM, Subar P, Young DA, Wong A. Dental Care 
for Geriatric and Special Needs Populations. Dent Clin North Am. 
2018;62:245-67.
2. Dodson WE. Special pharmacokinetic considerations in children. 
Epilepsia. 1987;28:S56-70.
3. Harbuz DK, O’halloran M. Techniques to administer oral, inhala-
tional, and IV sedation in dentistry. Australas Med J. 2016;9:25-32.
4. Sebastiani FR, Dym H, Wolf J. Oral Sedation in the Dental Office. 
Dent Clin North Am. 2016;60:295-307.
5. Jensen B, Matsson L. Benzodiazepines in child dental care: a survey 
of its use among general practitioners and paediatric dentists in Swe-
den. Swed Dent J. 2001;25:31-8.
6. Laqueille X, Uribe M, Olie JP. Current clinical aspects of drug ad-
diction. Rev Prat. 1995;45:1359-63.
7. Sivasubramani SM, Pandyan DA, Chinnasamy R, Kuppusamy SK. 
Comparison of Bite Force After Administration of Midazolam and 
Dexmedetomidine for Conscious Sedation in Minor Oral Surgery. J 
Pharm Bioallied Sci. 2019;11:S446-9.
8. Guina J, Merrill B. Benzodiazepines I: Upping the Care on Dow-
ners: The Evidence of Risks, Benefits and Alternatives. J Clin Med. 
2018;7:E17.
9. Flanagan D. Oral triazolam sedation in implant dentistry. J Oral Im-
plantol. 2004;30:93-7.
10. Coke JM, Edwards MD. Minimal and moderate oral sedation in 
the adult special needs patient. Dent Clin North Am. 2009;53:221-30. 
11. Loeffler PM. Oral benzodiazepines and conscious sedation: a re-
view. J Oral Maxillofac Surg. 1992;50:989-97.
J Clin Exp Dent. 2019;11(12):e1170-4.                                                                                                                                                                          Benzodiazepines in dental care of special needs
e1174
12. Araujo JO, Motta RHL, Bergamaschi CC, Guimaraes CC, Ramac-
ciato JC, De Andrade NK, et al. Effectiveness and safety of oral se-
dation in adult patients undergoing dental procedures: protocol for a 
systematic review. BMJ Open. 2018;8:e017681.
13. Conway A, Rolley J, Sutherland, JR. Midazolam for sedation befo-
re procedures. Cochrane Database Syst Rev. 2016;5:CD009491.
14. Jerath A, Panckhurst J, Parotto M, Lightfoot N, Wasowicz M, 
Ferguson ND, et al. Safety and Efficacy of Volatile Anesthetic Agents 
Compared With Standard Intravenous Midazolam/Propofol Sedation 
in Ventilated Critical Care Patients: A Meta-analysis and Systematic 
Review of Prospective Trials. Anesth Analg. 2017;124:1190-9.
15. Smith R, Brown J. Midazolam for status epilepticus. Aust Prescr. 
2017;40:23-5.
16. Moreira TA, Costa PS, Costa LR, Jesus-Franca CM, Antunes DE, 
Gomes HS, et al. Combined oral midazolam-ketamine better than mi-
dazolam alone for sedation of young children: a randomized controlled 
trial. Int J Paediatr Dent. 2013;23:207-15.
17. Lima ARA, Da Costa LRRS, DA Costa PSSS. A randomized, con-
trolled, crossover trial of oral midazolam and hydroxyzine for pedia-
tric dental sedation. Pesqui Odontol Bras. 2003;17:206-11.
18. Papineni A, Lourenco-Matharu L, Ashley PF. Safety of oral mi-
dazolam sedation use in paediatric dentistry: a review. Int J Paediatr 
Dent. 2014;24:2-13.
19. Masuda R, Nonaka M, Nishimura A, Gotoh K, Oka S, Lijima T. 
Optimal and safe standard doses of midazolam and propofol to achie-
ve patient and doctor satisfaction with dental treatment: A prospective 
cohort study. PLoS One. 2017;12:e0171627.
Conflict of Interest
The authors declare that they have no conflict of interest.
